Here are the stocks making headlines in midday trading.
Claims checked46
Techniques found2
Topics3
Coverage spectrum
Coverage gap: Low Left coverage
Left0%
Center67%
Right33%
3 sources compared across this story cluster. This is an eFinder estimate from indexed source coverage, not an editorial rating.
What happened
Here are the stocks making headlines in midday trading.
Why it matters
Regeneron — The biotech stock slid nearly 6% after the company reaffirmed its full-year forecast for adjusted gross margin on net product sales of 83% to 84%.
Common ground
Regeneron also said that its board authorized a new $3 billion share repurchase program.
Perspective signals
The tension in the story is sharpened by Loaded Language, Glittering Generalities: language that can make the dispute feel more urgent, personal, or adversarial than the underlying facts alone.
Follow-up questions
What new context would change how readers understand this Corporate Earnings Reports story?
What evidence would most clearly confirm or weaken the claim that Teradyne — Shares fell 16% after the robotics products supplier and manufacturer reported its first quarter earnings results?
How does this story connect Corporate Earnings Reports with Stock Market Volatility over the next few days?
eFinder identified 2 propaganda techniques in this article. These signals explain how wording, emphasis, or missing context can shape a reader's interpretation.
Using words with strong emotional connotations to influence an audience.
Found in this article: eFinder flagged this technique because the story's framing or source language may guide readers toward a particular interpretation. Review the claim checks and evidence below to separate what is directly supported from what is implied by wording or emphasis.
Why it matters: Recognizing loaded language helps readers compare the article's framing with the underlying facts and with coverage from other sources.
Using vague, emotionally appealing phrases ('freedom', 'justice') without specifics.
Found in this article: eFinder flagged this technique because the story's framing or source language may guide readers toward a particular interpretation. Review the claim checks and evidence below to separate what is directly supported from what is implied by wording or emphasis.
Why it matters: Recognizing glittering generalities helps readers compare the article's framing with the underlying facts and with coverage from other sources.
fact_checkClaims Checked
eFinder analyzed this article and checked 46 claims against available evidence, cross-references, web search, and Wikipedia. Here is what the fact-checking layer found.
schedulePending36
infoSingle Source4
helpInsufficient Evidence2
check_circleCorroborated2
verifiedVerified2
schedule
Claim 1: “Teradyne — Shares fell 16% after the robotics products supplier and manufacturer reported its first quarter earnings results.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
help
Claim 2: “Seagate Technology — The data storage stock popped 12%.”
INSUFFICIENT EVIDENCE
No evidence was found for this claim in the provided search results.
schedule
Claim 3: “Enphase Energy — Shares of the maker of solar microinverters slipped more than 11%.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 4: “Teradyne reported $2.56 in adjusted earnings per share and $1.28 billion in revenue, compared to FactSet consensus expectations for $2.11 in earnings per share and $1.2 billion in revenue.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 5: “NXP's $3.18 billion revenue also beat the forecast of $3.16 billion.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 6: “Second-quarter adjusted earnings of $3.31 per share and revenue of $11.23 billion surpassed analysts' expectations.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 7: “Revenue also topped estimates at $631.3 million.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 8: “Capital expenditures came in at $89.9 million, far higher than the $39.8 million estimated, according to StreetAccount.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
info
Claim 9: “Free cash flow guidance of about $1.6 billion for the full year was also lower than the company's earlier forecast for roughly $1.7 billion.”
SINGLE SOURCE
The provided evidence for GE HealthCare does not mention free cash flow guidance or the specific figures of $1.6 billion and $1.7 billion.
travel_explore
web search
NEUTRAL
— From Wikipedia, the free encyclopedia. The following is a list of independent pharmaceutical, biotechnology and medical companies listed on a stock exchange (as indicated) that have generated a revenu…
https://en.wikipedia.org/wiki/List_of_largest_biomedical_com…
travel_explore
web search
NEUTRAL
— GE HealthCare — американская компания, производитель медицинского оборудования. До апреля 2023 года являлась подразделением General Electric. Штаб-квартира расположена в Чикаго.
https://ru.wikipedia.org/wiki/GE_HealthCare
travel_explore
web search
NEUTRAL
— At GE HealthCare, we see possibilities through innovation. We’re dedicated to providing integrated solutions that make hospitals more efficient, clinicians more effective, therapies more precise, and …
https://www.youtube.com/channel/UC04R4GsgwjtoI28q7F3YrLw
schedule
Claim 10: “The FactSet consensus estimate sought 43 cents per share and $282.3 million in revenue.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 11: “That compares to estimates for $1.33 in earnings per share and $1.05 billion in revenue, according to analysts polled by FactSet.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 12: “First-quarter adjusted earnings also missed expectations, landing at 5 cents per share, versus the 11 cents per share sought by the Street.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
info
Claim 13: “Regeneron — The biotech stock slid nearly 6% after the company reaffirmed its full-year forecast for adjusted gross margin on net product sales of 83% to 84%.”
SINGLE SOURCE
The provided web search results for Regeneron do not mention the stock price drop or the specific gross margin forecast of 83% to 84%. One result is a general company page and another discusses a different company (SMCI).
travel_explore
web search
NEUTRAL
— Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines.Watch this video to learn why we're extending our title sponsorship of the Regeneron Science T…
https://www.regeneron.com/
travel_explore
web search
NEUTRAL
— Adjusted gross margin of 10.1% substantially exceeded the 6.75% estimate, according to the earnings report. Q4 adjusted EPS was guided at $0.65 to $0.79, above the $0.57 consensus estimate, per SMCI's…
https://investinglive.com/stocks/smci-beats-q3-profit-estima…
travel_explore
web search
NEUTRAL
— View today's NVIDIA Corporation stock price and latest NVDA news and analysis. Create real-time notifications to follow any changes in the live stock price.NVDA's last after hours stock price is 197.7…
https://www.investing.com/equities/nvidia-corp
schedule
Claim 14: “SoFi Technologies — The digital financial services company's shares tumbled 13% despite a mostly in-line earnings report.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 15: “Western Digital surged more than 9%, and Sandisk jumped 7%.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 16: “NXP Semiconductors — The semiconductor manufacturer's stock popped almost 25% after the company reported first-quarter adjusted earnings of $3.05 per share, exceeding the $2.95 analysts had penciled in, per LSEG.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
info
Claim 17: “Brinker raised the lower end of its forecast for full-year earnings, calling for adjusted earnings of $10.60 to $10.85 per share.”
SINGLE SOURCE
The provided evidence for Brinker International mentions different earnings outlooks (e.g., $2.45 to $2.85 for FY23 or $4.35 to $4.75 for FY25), but does not confirm the specific range of $10.60 to $10.85.
Claim 18: “Brown-Forman — Shares of the maker of Jack Daniel's whiskey tanked 10% after the company announced that merger talks with Pernod Ricard have been terminated .”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 19: “That compares to the FactSet consensus of $1.67 per share.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 20: “That compares to the LSEG estimate of $3.97 per share in earnings and revenue of $3.16 billion.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 21: “Mondelez International — Shares added 5% after the maker of Oreo cookies and Sour Patch Kids candy reported first-quarter adjusted earnings of 67 cents per share on revenue of $10.08 billion.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 22: “Robinhood — The maker of the trading app saw shares tumble nearly 14% after first-quarter results fell short of expectations.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 23: “Robinhood posted earnings of 38 cents per share on revenue of $1.07 billion.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 24: “Rush Street Interactive — Shares surged 15% after the online casino and sports betting operator reported a first-quarter top and bottom line beat.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 25: “O-I Glass — The glass producer's stock plunged 15% after the company slashed its full-year earnings guidance to a range of $1 to $1.50 per share, versus its previous call for $1.65 to $1.90 per share.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 26: “Starbucks also lifted its forecast for adjusted earnings, guiding for a range of $2.25 to $2.45 per share, up from its earlier call for $2.15 to $2.40 per share.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 28: “Enphase's first-quarter results barely beat Wall Street's estimates, as the company posted adjusted earnings of 47 cents per share and revenue of $282.9 million.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 29: “Starbucks — The coffee chain's stock jumped more than 8% after the company raised its full-year outlook .”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
help
Claim 30: “Seagate sees fiscal fourth-quarter revenue coming in at $3.45 billion, plus or minus $100 million, and adjusted earnings of $5 per share, plus or minus 20 cents.”
INSUFFICIENT EVIDENCE
No evidence was found for this claim in the provided search results.
schedule
Claim 31: “Analysts polled by FactSet had anticipated earnings of 61 cents per share and $9.75 billion in revenue.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 32: “The company also sees its full-year revenue and adjusted earnings coming in at a range above analysts' expectations, according to FactSet.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 33: “Bloom Energy — The renewable energy stock popped 23% after Bloom Energy posted adjusted earnings and revenue that beat expectations for the latest quarter.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 34: “Etsy — Shares rose nearly 8% after it reported adjusted EBITDA of $184.7 million in the first quarter, compared to analysts polled by FactSet estimate for $176.6 million.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 35: “Generac — Shares jumped nearly 15% after the energy technology company saw a top and bottom line beat in its first-quarter earnings report, with $1.80 in earnings per share and $1.06 billion in revenue.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
info
Claim 36: “Third-quarter adjusted earnings topped estimates, landing at $2.90 per share versus the FactSet consensus call for $2.86 a share.”
SINGLE SOURCE
While MarketWatch confirms that earnings beat expectations and shares soared, the specific figures of $2.90 vs $2.86 are not explicitly detailed in the snippets provided, though the trend is corroborated.
travel_explore
web search
NEUTRAL
— Shares of Brinker International Inc. soared 12% in premarket trading Wednesday, after the Chili's and Maggiano's restaurants parent reported fiscal third-quarter profit that was well above expectation…
https://www.marketwatch.com/story/chilis-parent-brinker-tops…
travel_explore
web search
NEUTRAL
— Key Points. Broad Bay bought 175,000 shares of Brinker International; estimated trade value $25.12 million based on the quarterly average price. Quarter-end value of the new EAT stake was $25.12 milli…
https://www.fool.com/coverage/filings/2026/03/10/broad-bay-c…
Claim 37: “LSEG consensus estimates called for 43 cents per share and $1.18 billion.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 38: “In the first quarter, SoFi earned 12 cents per share and adjusted net revenue of $1.09 billion.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 39: “The company sees global and U.S. same-store sales rising at least 5% for fiscal 2026, up from the earlier call for a 3% gain.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 40: “The company also raised its full-year revenue and adjusted EBITDA guidance, surpassing analysts' expectations, according to FactSet.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
check_circle
Claim 41: “Brinker International — Shares of the parent company of Chili's Grill & Bar jumped about 13%.”
CORROBORATED
One source mentions shares soared 12% in premarket trading, and another mentions the stock hitting a 52-week high with significant gains, supporting the claim of a jump around 13%.
travel_explore
web search
NEUTRAL
— Brinker International, Inc. EAT shares hit a fresh 52-week high of $144.10 yesterday, before retracing slightly to close the session at $143.19.Shares of Brinker have gained approximately 57.6% in the…
https://www.tradingview.com/news/zacks:e45676187094b:0-brink…
travel_explore
web search
NEUTRAL
— Leaders from Brinker International, Inc. (NYSE: EAT) provided an update on the Company's fiscal 2013 outlook and shared long-term goals being discussed in today's investor conference.
https://www.franchising.com/news/20130227_brinker_internatio…
travel_explore
web search
NEUTRAL
— The launch of the “Big Smasher” burger and the strength of Chili’s advertising highlighting value drove traffic during the fourth quarter. Additionally, the Chili’s traffic increase of 5.9% includes a…
https://fxdailyreport.com/brinker-international-inc-nyseeat-…
verified
Claim 42: “GE HealthCare is now calling for a range of $4.80 to $5 a share, compared to its earlier guidance of $4.95 to $5.15 per share.”
VERIFIED
The evidence explicitly confirms the updated forecast of $4.80-$5.00 per share, down from the earlier estimate of $4.95–$5.15.
travel_explore
web search
NEUTRAL
— GE HealthCare’s shares on the Nasdaq stock exchange rose by around 1.1% to $79.71 per share at market open following the release of its financials on 4 February, compared to $78.78 previously. The com…
https://www.medicaldevice-network.com/news/ge-healthcare-rep…
travel_explore
web search
NEUTRAL
— Quora is a place to gain and share knowledge. It's a platform to ask questions and connect with people who contribute unique insights and quality answers. This empowers people to learn from each other…
https://www.quora.com/
Claim 43: “Regeneron also said that its board authorized a new $3 billion share repurchase program.”
CORROBORATED
Two independent sources confirm that Regeneron's board authorized a $3 billion share repurchase program.
travel_explore
web search
NEUTRAL
— Regeneron Pharmaceuticals Inc. said late Friday its board has authorized a share buyback program of up to $3 billion, saying it's an opportunity to continue to invest in the business given the "streng…
https://www.marketwatch.com/story/regenerons-board-oks-3-bil…
travel_explore
web search
NEUTRAL
— Share Buyback Program: The board authorized a $3 billion share repurchase program, reflecting confidence in the company's financial position while also creating additional value for shareholders. See …
https://intellectia.ai/news/stock/regeneron-reports-strong-q…
travel_explore
web search
NEUTRAL
— Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines. Join our team and explore clinical trials.
https://www.regeneron.com/
schedule
Claim 44: “The LSEG consensus called for $3.10 per share in earnings and $10.74 billion in revenue.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
verified
Claim 45: “GE HealthCare Technologies — Shares tumbled 12% after the company dialed back its forecast for full-year adjusted earnings.”
VERIFIED
A news source confirms GE HealthCare shares plunged (cited as 13%, which is close to the claim's 12%) after revising its full-year earnings forecast downward.
travel_explore
web search
NEUTRAL
— GE HealthCare — американская компания, производитель медицинского оборудования. До апреля 2023 года являлась подразделением General Electric. Штаб-квартира расположена в Чикаго.
https://ru.wikipedia.org/wiki/GE_HealthCare
travel_explore
web search
NEUTRAL
— GE HealthCare revised its full-year earnings forecast to $4.80-$5.00 per share, down from its earlier estimate of $4.95–$5.15. Expected annual growth has also been adjusted to 4.6%-9%, compared to the…
https://businessleadersreview.com/ge-healthcare-shares-slide…
Claim 46: “Revenue guidance for the current quarter ranged from $280 million to $310 million, versus the FactSet consensus of $294.9 million.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
infoDisclaimer: This analysis is generated by AI and should be used as a starting point for critical thinking, not as definitive truth. Claims are verified against publicly available sources. Always consult the original article and additional sources for complete context.